# Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

> **NCT01248780** · PHASE3 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 264 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Golimumab
- **DRUG:** Placebo
- **DRUG:** Methotrexate (MTX)

## Key facts

- **NCT ID:** NCT01248780
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-10
- **Final completion:** 2012-07
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2013-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248780, "Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01248780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*